A comparative study of several kit reagent methods for determining serum thyroxine (T-4) was recently reported (Watson and Lees, 1973.) This laid stress on two related factors-precision (repeatability) and simplicity. However, a comparison of thyroxine results from different laboratories using dissimilar methods-if it were based solely on these two factors-would be hazardous because each laboratory may produce inaccuracies of unknown direction and magnitude. Few, if any, clinical assays show as great a diversity in their 'normal values' as does serum thyroxine (see Table I ). Some published ranges have an upper limit even higher than the well-established serum proteinbound total iodine level of 8~g/IOO mI.
We have, therefore, tried to establish more accurate values for thyroxine in human sera. This necessitates the provision and use of a reference or referendary standard thyroxine (pure preparation) in addition to a reference (quality control) serum. The importance of accuracy in clinical assays has been clearly stated by one of us. 'A reference (true) (Warneret al., 1970 Chilcott) All values are In terms of free acid and have been corrected for procedural losses where necessary, 2 standard is distinct from a control .... Whatever precision control is used it must always be in addition to and not in place ofthe reference (primary) standard" (Watson, 1963) .
In the present paper we collate data obtained accumulatively during the course of two years, normal service work. This reveals insurmountable difficulties in establishing a correct T-4 value by competitive protein-binding methods when relying on commercially supplied reagents and 'standards'. A close and hard look at existing primary and serum T-4 standards has been made, and a tentative procedure for the standardisation of T-4 assays in clinical laboratories is presented. Stock alcoholic thyroxine solution (approximately 20 mg/I 00 ml) About 40 mg thyroxine or thyroxine sodium salt pentahydrate are accurately weighed, suspended in 5 ml ethanol and dissolved with the aid of 50111 HCI and made up to 200 ml with solution 1. Thyroxine (free acid) was obtained from Fluor Chern Ltd., Mann Research Labs and Sigma and stored stoppered in a dessicator over P 2 0 S ' Thyroxine (sodium salt, pentahydrate) was obtained from Aldrich Chemical Co., Calbiochem, Koch-Light, Schwarz-Mann and Sigma, and stored at 4-10°C. All T-4 preparations should be protected from light.
MATERIALS AND METHODS

Solvents for thyroxine solutions
Standardisation of stock thyroxine in CO 2-free NaOH solution
The stock T-4 solution is diluted 1 in 20 with NaOH, 0.04 mol/I, prepared in CO 2-free de-ionised water. This gives a solution containing about 10 mg T-4/1 that is stable for less than 1 h. The absorbance (A) at 324 nm is measured in a stoppered 40 mm cuvette against a blank solution of solvent similarly diluted 1 in 20 with NaOH, 0.04 mol/I, The millimolar absorbance Emma! = A/4 X M.Wt./mmol/1.
Working standard alcoholic thyroxine (approximately 5 us T-4/1oo ml)
The freshly prepared stock thyroxine-NaOH is diluted 1 in 200 with solution 2 to give a solution containing Emma! x 5.0/6.1 Ilg T-4/1oo ml. This keeps at least one year.
Secondary thyroxine-in-serum standards
The following were examined: Lyophilised human serum (pooled from U.S.A.) which, on reconstitution, produces a serum with a stated T-4I value of 4.6 us (batch 0022), 4.8 us (batch 0025) or 5.01lg (batches 0010, 0012, 0014) per 100 ml, The given value had been obtained by standardisation against a frozen reference serum assayed for T-4 by the Murphy-Pattee and P.B.I. methods (H. K. Watson, personal communication) . The product was the 'Tetralute' standard (Ames).
Lyophilised human serum (pooled from U.S.A.) which, on reconstitution, produces a serum with a T-4 value of about 11 Ilg/1oo ml depending on the particular batch. The given value had been obtained from a reference laboratory P.B.I. result, after weighing thyroxine into thyroxine-freed serum (J. C. Charlton, personal communication). The product was the 'Thyopac-4' standard (R.C.C.).
Lyophilised human serum from Oxford Laboratories: Normal Control 14205. The given P.B.I. value was 4.4 Ilg/1oo ml.
Two Iyophilised human sera from Oxford Laboratories: Elevated Controls 14208 and 14210. The given P.B.I. values were 10.4 and 9.8 Ilg/1oo ml respectively.
Horse serum (Burroughs Wellcome). The solution (BW5T) was prepared with added thyroxine as described previously (Watson and Lees, 1973) . It contained about 11 Ilg T-4I/loo mI.
Liquid human sera-Hypocontrol serum 6720, and hypercontrol serum 6721 supplied by Abbott were also examined.
Determination of thyroxine
The following kit methods were used: the 'ResoMat' (Mallinckrodt), 'Tetrakit' (CIS, U.K. distributors Micro-Bio Labs Ltd.); 'Tetrasorb' (Abbott) procedure unmodified; 'Tetralute' (Ames) slightly modified (Watson and Lees, 1973) ; and 'Thyopac-4' (Radiochemical Centre).
Determination of tri-iodothyronine
This was carried out on the standard alcoholic thyroxine solutions, by a modification of the method of Hufner and Hesch (1973) .
Efficiency of T-4 extraction from serum
Serum T-4 extraction in 67 % ethanol was determined as previously described (Watson and Lees, 1973) . In the case of the 'Tetralute' method extraction of endogenous serum T-4 was measured from the retention values obtained using 50, 100, 150, 200~l of the same human serum, and by recovery experiments from the fortified Burroughs Wellcome horse serum (BW5T).
Temporary reference method
Our choice was for the resin-sponge method CTetrasorb') and was made on the following grounds:
1. Familiarity and good experience with the method, 2. Good repeatability (C.V. = 5 %) both for within and between batches (Watson and Lees, 1973 ) and 3. Sustained precision over 4-5 years. This was proved for 1972, when acceptable variation (C. V. = 5 %) was found in repeated control analyses both of an alcoholic solution of T-4 (Koch-Light) and of a T-4-fortified Burroughs Wellcome control serum (see Table 2 ).
For standardisation, this temporary reference method utilises a given T-4 solution prepared in barbiturate buffer containing 0.25 % bovine albumin. This standard solution is not taken through the entire analysis but used neat, without evaporation, to provide confirmation of standard points on a calibration curve previously determined and supplied by Abbott Pharmaceuticals with each batch of reagents.
RESULTS
The temporary reference method (T.R.M.) was used at fairly regular periods throughout 1972 and 1973 to assay various secondary standards (Tables 3,  4 and 6). From the results shown in Table 3 , we can conclude that the Ames secondary serum standard has not always contained the content stated on the bottle. Since the end of June, 1972, its thyroxine content has been about 15 % higher than previously. This suggests that use of the Ames 'kit' as supplied could at the present time give results about 30% lower than those given by the T.R.M. (Table 3 ). In practice it gave results on average 22-23 % lower than those of the T.R.M. (see Table 5 ).
The results given in Table 4 show that the R.C.C. serum standard too, does not always contain the amount stated on the bottle and the thyroxine content varies by some 20 % as judged by calibration against the T.R.M. At the time of writing (May, 1973) the method for which the R.C.C. standard is supplied (Thyopac 4') could on account of this standard, give results about 13 % lower than those given by the T.R.M. (Table 4 ). In practice during April and May, 1973 the patients' serum T-4 values were on average 21 % lower than those obtained by the T.R.M. (see Table 5 ). During the period October, 1972 -February, 1973 the R.C.C. serum standard (F) when analysed by the T.R.M. gave T-4 values close to the figure stated on the bottle (Table 4 ). This is in accordance with the fact that this was the only period of time during which the sera of our patients gave similar T-4 values by the R.C.C. method and by the T.R.M. (Table 5 ). Table 6 shows the results obtained for T-4 analyses of the Oxford control sera using three methods. These results again indicate consistently lower assay figures by the "Tetralute' method than by the T.R.M. The 'Thyopac' results for the Oxford sera were appreciably higher than those given by the T.R.M. (Table 6 ). On the other hand the 'Thyopac' results for patients sera were at no time in the past three years higher than those found by the T.R.M. (Table 5) Experiments to determine the ethanol extraction efficiency of the secondary thyroxine-in-serum standards showed that at a room temperature of 18°C a higher percentage of T-4 was extracted from the reconstituted RC.C. standard sera, the Oxford control sera and the Ames standard sera than from patients sera or from the liquid hypocontrol serum (Abbott) ( Table 7) .
Recovery of T-4 added to horse serum by the 'Tetralute' method was 93,106,101,94,97,108,97, mean 99 %. Similar retention values were found using either serum BW5T or stock T-4/NaOH suitably diluted in NaOH 0.04 molj]. The working standard alcoholic T-4 was unsuitable for use with this method.
Values for the apparent T-3 content and the 'Mean of at least two analyses ofa 12118 T-4/100 mlsolution. Table 9 . Given and determined adult normal serum T-4 values (lJg T-4/llOO ml) using five popular radio-displacement analysis kits.
Kit Stated normal range Determined normal range
ResoMat (Mallinckrodt) 3.3-8.9
3.5-8.5 (n = 56) Tetralute (Ames) 3.5-8.2
2.8-7.5 (n = 1 (0) Tetrakit (C.I.S.) 'approx.' 2.3-7.2 2.4-7.2 (n = 12) Tetrasorb (Abbott) 3.5-8.5
3.5-8.6 (n = 370) Thyopac-4 (Radiochemical Centre) 'about' 2.9-8.5
2.4-7.6 (n = 2 (0) working temperature (10 ± 2°C) were avoided, so that the change in ethanol extractability of T-4 from serum which occurs with temperature and is pertinent to all methods except 'Thyopac-4' and 'Tetralute' was avoided. Hence it seems reasonable to conclude that the apparent between-method differences in our average patient serum T-4 value (Table 5 ) reflect real differences inherent in the methods and/or the relevant 'standards' used during this time. Possible method bias resulting from the different viscosities of the standards and samples could not be demonstrated. Minor inherent faults have previously been demonstrated in two methods. The 'Tetrasorb' method is inaccurate owing to the presence of bovine albumin in the 'standard', and a correction of about -0.7 Ilg T-41 per l00ml is required. A source of inaccuracy in the 'Thyopac-4' method is the reconstituted 'standard' from which alcohol extracts a higher percentage of T-4 than it does from most patients' serum and a correction is needed of up to + 10% to the value found (Watson and Lees, 1973) . However, these component errors do not account for the different method results, in particular the gap between the 'Tetrasorb' values and the much lower 'Tetralute' figures. As illustrated in Table 1 , one C.P.B. method (Fitzgerald et al., 1970) has previously been reported to give an upper normal serum T-4 level almost twice that found by another C.P.B. method (Robin et al., 1971) . The present and past findings can most satisfactorily and for the major part be accounted for by variation in the standard at source.
Our study of eight different T-4 preparationslimited to U.V. absorbance in alkali, T-4 analysis by a reference method and apparent T-3 contentreveals very appreciable differences in quality. No attempt was made to dry or purify these preparations. With the unexplained exceptions of the Schwarz-Mann and the Mann Research compounds, preparations giving the higher assay figures have the higher molar absorbances. These latter values approach 6.1 which is less than the figure of 6.207 found by Gemmill (1955) . Unfortunately, no details of the quality of Gemmill's ('Bios') preparation are given. In general, the higher the T-3 content of the compound the lower the molar absorbance at 324 nm. Some makes of thyroxine are seen to contain more than 5 % impurity in the form of other thyronines, visible iodine and extraneous moisture (Table 8) .
From these findings, it is clear that standardisation with the purest preparation leads to the production of lower serum T-4 values than are frequently accepted. The determined normal range with 'Tetralute' (Table 9) seems close to the correct values. In the past, therefore, serum T-4 results have been clinically interpreted correctly because both the results and their normal range were-for some methods-higher than they should have been. In other cases the results obtained, as for example by the so-called column method (based on 1 2 determinations in extracted T-4) are too low (Table 1) . Inherent losses (unpublished observations) make these methods unsatisfactory for clinical use.
A disturbing feature of this work was the apparent change in T-4 content which occurred in the Ames 'standard' in late June, 1972 and in the Radiochemical Centre 'standard' in October, 1972 . The alternative explanation that on these occasions the reference method 'standard' was less or more inaccurate than at other times seems disproved by the constancy with which the laboratory-prepared controls were assayed (Table 2 ). However, commercial serum controls for thyroxine, as for any other constituent of clinical interest, should not be used as standards because they are not available in a reproducible definable solvent. Apparently the Oxford control serum contains something which causes 'Thyopac-4' to over-estimate the T-4 content, since the other explanation that both 'Tetrasorb' and 'Tetralute' grossly under-estimate it seems most unlikely (see Tables 5 and 6 ).
It is concluded that of the methods studied, 'Tetralute' produced the most accurate results, while the 'Tetrasorb' and 'Tetralute' methods gave in our hands results of similar precision (Watson and Lees, 1973 ; also Table 6 ). The determined normal range by the 'Thyopac-4' method was marginally the widest found, whilst the stated normal range for 'Tetralute' is not low enough (Table 9 ) and if used without an independent check leads to the misreporting of about 10% euthyroid patients as hypothyroid.
There is a pressing need for a certified standard reference thyroxine, well characterised and available to all. In the meantime, we recommend that the standardisation of serum T-4 assays should be made with a working standard solution of T-4 in alcohol or other definable solution (i.e. not serum) and that this be derived from the purest available preparation standardised by U.V. spectrometry as described.
Notice to Contributors
In future all manuscripts submitted for publication, and all inquiries regarding the Journal, subscriptions,or advertisements should be sent to the new Editor, Professor N. F. Maclagan, at the British Medical Journal, BMA House, Tavistock Square, London weIH 9JR.
